A cyclase II Antibodies

Santa Cruz Biotechnology delivers a wide array of A cyclase II monoclonal antibodies for research focused on understanding adenylate cyclase type 2 function. A cyclase II monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). A cyclase II, also known as adenylate cyclase type 2, plays a crucial role in the regulation of intracellular cyclic AMP levels, which are vital for numerous cellular processes, including signal transduction, neuronal function, and cardiac contractility. Dysregulation of A cyclase II has been implicated in various diseases, making it a significant target for therapeutic intervention and research. Understanding the function and regulation of A cyclase II is essential for elucidating its contributions to health and disease. A cyclase II research spans multiple areas including neuroscience, cardiology, and cell signaling pathways. Ongoing studies continue to reveal new functions and regulatory mechanisms of A cyclase II in different physiological contexts. Research utilizing A cyclase II monoclonal antibodies from Santa Cruz Biotechnology enables scientists to advance understanding of cellular signaling mechanisms and potential therapeutic applications.